In Silico Drug Discovery: Unveiling Potential Targets in Plasmodium falciparum through Molecular Docking Analysis

Author:

Murugesan 1ORCID,kaleeswaran 1

Affiliation:

1. A Veeriya Vandayar Memorial Sri Pushpam College (An Autonomous Institution Affiliated to Bharathidasan University)

Abstract

Abstract

The most significant human health problem is malaria, caused by the Plasmodium parasite and affecting nearly half of the global population. Malaria results in an annual death toll ranging from 1.2 to 2.7 million worldwide. Consequently, there is a pressing need for novel active ingredients with targeted effects to curb the worldwide spread of malaria. The objective of the present research was to explore innovative pharmacological molecules and employ bioinformatics methods for the development of effective anti-malarial drugs. As part of the latest anti-malarial chemical development, our study identified seven drug combinations from various databases demonstrating drug-like properties and robust anti-malarial activity in silico. Dioncophyllin-A, hugorosenone, marmesine, oxyprotostemonin, pachyrrhizin, plumbagin, and stemocurtisin were subjected to docking against the hexokinase-1 protein (PDB: 1CZA). Among the pachyrrhizin compounds, the one with the highest docking score (-9.9 kcal/mol) was directed towards the 1CZA protein. Through superimposing the target and template structures, the active centres of the hexokinase I protein were identified, revealing structurally identical folds and undoubtedly conserved active sites. The SWISS-ADME tool was employed to assess the excellent absorption, distribution, metabolism, and excretion (ADME) properties of the investigated drug candidates. In summary, our research identifies seven potential anti-malarial drug combinations with strong in silico activity. We've elucidated their interaction with the hexokinase-1 protein and assessed their favourable pharmacokinetic properties. These findings represent a significant step toward developing effective treatments for malaria, emphasizing the importance of further experimental validation and clinical studies.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.7亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3